PROCEPT BioRobotics Corporation PRCT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 98.29M | 94.50M | 83.13M | 76.38M | 83.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 98.29M | 94.50M | 83.13M | 76.38M | 83.33M |
| Cost of Revenue | 33.14M | 35.02M | 29.19M | 30.07M | 29.32M |
| Gross Profit | 65.15M | 59.48M | 53.95M | 46.31M | 54.01M |
| SG&A Expenses | 72.51M | 69.67M | 65.09M | 58.30M | 59.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 125.67M | 124.79M | 115.74M | 107.42M | 106.52M |
| Operating Income | -27.38M | -30.29M | -32.61M | -31.04M | -23.19M |
| Income Before Tax | -26.57M | -26.77M | -31.68M | -29.66M | -21.38M |
| Income Tax Expenses | -58.00K | 94.00K | -43.00K | 190.00K | 34.00K |
| Earnings from Continuing Operations | -26.52M | -26.86M | -31.64M | -29.85M | -21.41M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.52M | -26.86M | -31.64M | -29.85M | -21.41M |
| EBIT | -27.38M | -30.29M | -32.61M | -31.04M | -23.19M |
| EBITDA | -24.84M | -28.30M | -30.87M | -29.33M | -21.57M |
| EPS Basic | -0.46 | -0.47 | -0.56 | -0.53 | -0.38 |
| Normalized Basic EPS | -0.29 | -0.32 | -0.35 | -0.33 | -0.24 |
| EPS Diluted | -0.46 | -0.47 | -0.56 | -0.53 | -0.38 |
| Normalized Diluted EPS | -0.29 | -0.32 | -0.35 | -0.33 | -0.24 |
| Average Basic Shares Outstanding | 57.33M | 57.07M | 56.51M | 56.07M | 55.73M |
| Average Diluted Shares Outstanding | 57.33M | 57.07M | 56.51M | 56.07M | 55.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |